The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy
Year: 2021
Type: article
Institutions: Cleveland Clinic, Case Comprehensive Cancer Center, University College London Hospitals NHS Foundation Trust, University College London, University of California San Diego, University of California, San Francisco, University of Nebraska Medical Center, City Of Hope National Medical Center, City of Hope, Northside Hospital, Washington University in St. Louis, Medical College of Wisconsin
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: British Microcirculation Society
OpenAlex ID: W4229063598